We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-0.67%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$17.5B
AUM Growth
+$1.25B
Cap. Flow
+$1.35B
Cap. Flow %
7.69%
Top 10 Hldgs %
15.74%
Holding
691
New
246
Increased
140
Reduced
132
Closed
135

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$274M
2
AAPL icon
Apple
AAPL
+$233M
3
SCHW
Charles Schwab
SCHW
+$200M
4
JBL icon
Jabil
JBL
+$185M
5
ZM icon
Zoom
ZM
+$163M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$269M
2
ORCL icon
Oracle
ORCL
+$215M
3
EL icon
Estee Lauder
EL
+$172M
4
DELL icon
Dell
DELL
+$160M
5
MSFT icon
Microsoft
MSFT
+$136M

Sector Composition

Rank Sector Weight
1 Technology 24.54%
2 Consumer Discretionary 14.14%
3 Healthcare 13.6%
4 Industrials 12.07%
5 Financials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBX
551
CALL
Wallbox
WBX
$81.5M
$30.7K ﹤0.01%
+1,170
New +$33.9K
DNA icon
552
CALL
Ginkgo Bioworks
DNA
$521M
$30.1K ﹤0.01%
+2,250
New +$67.1K
SES icon
553
CALL
SES AI
SES
$208M
$25.8K ﹤0.01%
+20,600
New +$28K
LILM
554
CALL
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$21.9K ﹤0.01%
+27,589
New +$25.9K
ARQQ icon
555
CALL
Arqit Quantum
ARQQ
$399M
$21.4K ﹤0.01%
+2,500
New +$27.1K
AAL icon
556
American Airlines Group
AAL
$10.6B
-2,035,874
Closed -$31.3M
ACAD icon
557
Acadia Pharmaceuticals
ACAD
$5.03B
-85,696
Closed -$1.58M
ADT icon
558
ADT
ADT
$5.58B
-3,400,000
Closed -$22.8M
AFMD
559
DELISTED
Affimed
AFMD
-35,000
Closed -$186K
AKR icon
560
Acadia Realty Trust
AKR
$2.84B
-607,305
Closed -$10.3M
ALGS icon
561
CALL
Aligos Therapeutics
ALGS
$34.9M
-244,129
Closed -$5.98M
AMD icon
562
Advanced Micro Devices
AMD
$789B
-407,424
Closed -$73.5M
AMP icon
563
Ameriprise Financial
AMP
$48.8B
-39,118
Closed -$17.2M
AMT icon
564
American Tower
AMT
$80.4B
-60,009
Closed -$11.9M
APLT
565
CALL
DELISTED
Applied Therapeutics
APLT
-4,000,000
Closed -$27.2M
AQST icon
566
Aquestive Therapeutics
AQST
$494M
-500,000
Closed -$2.13M
ARM icon
567
Arm
ARM
$302B
-80,201
Closed -$10M
AXDX
568
DELISTED
Accelerate Diagnostics
AXDX
-80,547
Closed -$79.7K
AYI icon
569
Acuity Brands
AYI
$10.8B
-2,946
Closed -$792K
BANC icon
570
Banc of California
BANC
$2.97B
-36,959
Closed -$562K
BLUE
571
DELISTED
bluebird bio
BLUE
-62,797
Closed -$1.61M
BROS icon
572
Dutch Bros
BROS
$9.26B
-198,073
Closed -$6.54M
CALC icon
573
CalciMedica
CALC
$10.9M
-75,082
Closed -$312K
CARR icon
574
Carrier Global
CARR
$52.8B
-136,615
Closed -$7.94M
CASY icon
575
Casey's General Stores
CASY
$30.9B
-32,177
Closed -$10.2M

Similar funds

Alyeska Investment Group's Q2 2024 Portfolio in Review

As of Q2 2024, Alyeska Investment Group held 691 positions worth $17.5B, up 7.7% from $16.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Alyeska Investment Group deployed $1.35B of net new capital in Q2 2024, opening 246 new positions and adding to 140 existing holdings. Its largest new stake was Qualcomm: 1,450,565 shares worth $289M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Oracle, an estimated $215M trimmed.

  • Alyeska Investment Group's largest Q2 2024 buy was Qualcomm: 1,450,565 shares worth $289M.
  • Alyeska Investment Group added most to Zoom in Q2 2024, an estimated $163M increase.
  • Alyeska Investment Group's biggest Q2 2024 reduction was Oracle, cutting an estimated $215M.
  • Alyeska Investment Group fully exited Alphabet (Google) Class A in Q2 2024, selling an estimated $269M.
  • Alyeska Investment Group's ten largest holdings make up 16% of its $17.5B portfolio in Q2 2024.
  • Alyeska Investment Group opened 246 new positions and closed 135 in Q2 2024.
  • Alyeska Investment Group's portfolio value rose 7.7% quarter-over-quarter to $17.5B.

Based on Alyeska Investment Group's 13F filing for Q2 2024, filed 14 Aug 2024.